Jenburkt Pharmaceuticals Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹37.01Cr |
Net Profits | ₹5.40Cr |
Net Profit Margins | 14.59% |
Highlights
Revenue:
Jenburkt Pharmaceuticals Ltd’s revenue jumped 2.72% since last year same period to ₹37.01Cr in the Q3 2023-2024. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -6.02% fall in its revenue since last 3-months.
Net Profits:
Jenburkt Pharmaceuticals Ltd’s net profit fell -0.55% since last year same period to ₹5.40Cr in the Q3 2023-2024. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -26.23% fall in its net profits since last 3-months.
Net Profit Margins:
Jenburkt Pharmaceuticals Ltd’s net profit margin fell -3.19% since last year same period to 14.59% in the Q3 2023-2024. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -21.51% fall in its net profit margins since last 3-months.
